A former senior executive in the U.S. pharmaceutical industry, Mr. Naj divides his time between overseeing medicine companies he has founded and writing; his latest book, Pandastic Times (Brazen House), is a fable of the Covid pandemic. Some two decades ago, when I mentioned what I did for a living …
Read More »
Donald Trump’s decision to appoint Robert F. Kennedy Jr. to lead the Health and Human Services Department is an alarming choice, given Kennedy’s fringe medical views and history of making misleading and often incorrect statements about health matters. Making things worse, the president-elect has opted to surround RFK Jr. with …
Read More »
The integration of cannabinoids into mainstream pharmaceutical practices has been a topic of significant debate and interest over the past decade. As scientific research continues to unravel the therapeutic potential of cannabinoids, the question remains: when will the pharmaceutical industry fully embrace these compounds as mainstream medicine? The Current Landscape …
Read More »